StockData
Veru Inc. logo

Veru Inc. (VERU) stock

VERUNasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 6/30
$2.08−0.01 (-0.48%)

Close on Nov 16, 2026Market cap $35.46MP/E –Yield –

Veru ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Veru's ebitda for the twelve months ending Jun 30, 2026 was -$19.08M. For fiscal 2025 it was -$24.60M. The highest annual figure on record is $11.40M in fiscal 2012.

Annual ebitda

PeriodPeriod endValueChange
FY2025Sep 30, 2025-$24.60M–
FY2024Sep 30, 2024-$35.90M–
FY2023Sep 30, 2023-$93.51M–
FY2018Sep 30, 2018-$20.70M–
FY2017Sep 30, 2017-$8.16M-337.1%
FY2016Sep 30, 2016$3.44M-51.6%
FY2015Sep 30, 2015$7.11M+57.6%
FY2014Sep 30, 2014$4.51M-56.4%
FY2013Sep 30, 2013$10.35M-9.3%
FY2012Sep 30, 2012$11.40M+203.2%
FY2011Sep 30, 2011$3.76M-21.9%
FY2010Sep 30, 2010$4.82M-3.4%
FY2009Sep 30, 2009$4.99M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026-$7.69M–
Q2 FY2026CQ1 2026Mar 31, 2026-$7.19M–
Q1 FY2026CQ4 2025Dec 31, 2025-$5.40M–
Q4 FY2025CQ3 2025Sep 30, 2025$1.20M–
Q3 FY2025CQ2 2025Jun 30, 2025-$7.52M–
Q2 FY2025CQ1 2025Mar 31, 2025-$8.09M–
Q1 FY2025CQ4 2024Dec 31, 2024-$10.18M–
Q4 FY2024CQ3 2024Sep 30, 2024-$9.28M–
Q3 FY2024CQ2 2024Jun 30, 2024-$10.48M–
Q2 FY2024CQ1 2024Mar 31, 2024-$8.82M–
Q1 FY2024CQ4 2023Dec 31, 2023-$7.32M–
Q4 FY2023CQ3 2023Sep 30, 2023-$8.11M–
Q1 FY2019CQ4 2018Dec 31, 2018-$969.17K–
Q4 FY2018CQ3 2018Sep 30, 2018-$3.73M–
Q3 FY2018CQ2 2018Jun 30, 2018-$4.92M–
Q2 FY2018CQ1 2018Mar 31, 2018-$4.65M–
Q1 FY2018CQ4 2017Dec 31, 2017-$7.39M–
Q4 FY2017CQ3 2017Sep 30, 2017-$2.71M–
Q3 FY2017CQ2 2017Jun 30, 2017-$1.18M–
Q2 FY2017CQ1 2017Mar 31, 2017-$2.49M–
Q1 FY2017CQ4 2016Dec 31, 2016-$1.79M–
Q4 FY2016CQ3 2016Sep 30, 2016-$197.75K–

More Veru figures

See a number that looks wrong?